… drugs. Novartis terminated the study after interim data suggested that Rasilez … in their other ongoing trials. Health Canada will … risks to the trial participants. Novartis is informing Canadian … guidance on medication and should not stop treatment until …

… French medical journal Prescrire specialized in diseases, medical techniques, drugs. The … there are 107 drugs to avoid. Medicines used in hematology … ) Vinflunina (Javlor) Drugs prescribed in cardiology Aliskiren (Rasilez) Bezafibrato (Befizal) Ciprofibrate …

… , which enables the optimized treatment of tissue-specific cataracts and … a new drug application with the FDA for its drug candidate Amphora … the AMPREVENCE Phase 2b trial evaluating Amphora for the … to lower sales volume of Rasilez in certain territories, in …

… and through trials and regulatory … drug candidates successfully through regulatory review to people who seek better treatments … experience in biotechnology and pharmaceutical companies including … Valturna®, Tekturna®/Rasilez®, Tekturna HCT®, Tekamlo®, …

… and debt facilities in the biotech, pharmaceutical and medical device industries. The operating … of the company are Medical Devices, Strategic Positions, Pharmaceutical and Income Generating … the U.S, and Rasilez and Rasilez HCT in the rest of …

… which enables the optimized treatment of tissue-specific cataracts … Rasilez are used by patients, who need these unique drugs … associated deferral of elective medical procedures. Turning to operating … these elective procedures. The doctors, they will work hard …